SEC Form 4 · accession 0001179110-16-031806
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Meanwell
Officer — CEO · Director
Period of report
Nov 15, 2016
Accepted (ET)
Nov 17, 2016 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2016 | M | 20,000 | $28.60 | A | 359,168 | D | |
| Common StockF1,F2 | Nov 15, 2016 | S | 20,000 | $40.0027 | D | 339,168 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F4,F3 | $28.60 | Nov 15, 2016 | M | 20,000 | D | — | Feb 16, 2017 | Common Stock | 20,000 | 40,000 | D |
Explanation of responses
- F1Sales were effected pursuant to a Rule 10b-5 program adopted by Dr. Meanwell.
- F2Represents the weighted average sales price of the shares sold ranging from a low of $40.00 to a high of $40.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This option vested in forty-eight equal installments beginning on March 16, 2007.
- F4Not applicable.